染色质与表观遗传失调在前列腺癌中的作用：从发生发展到进展及治疗反应
Role of Chromatin and Epigenetic Dysregulation in Prostate Cancer: From Development to Progression and Therapeutic Response.
作者信息
Paleati Nikhila, Munirathinam Gnanasekar
机构信息
Department of Psychology and Neuroscience, College of Undergraduate Studies, Nova Southeastern University, Fort Lauderdale, FL 33328, USA.
Department of Biomedical Sciences, College of Medicine, University of Illinois, Rockford, IL 61107, USA.
出版信息
Cancers (Basel). 2023 Nov 29;15(23):5638. doi: 10.3390/cancers15235638.
Abstract
A multitude of epigenetic modifications and genetic mutations have been found to play pivotal roles in the development and progression of prostate cancer (PCa) [...].
摘要
人们发现众多表观遗传修饰和基因突变在前列腺癌（PCa）的发生发展过程中起着关键作用[……]
相似文献
1
Role of Chromatin and Epigenetic Dysregulation in Prostate Cancer: From Development to Progression and Therapeutic Response.
Cancers (Basel). 2023 Nov 29;15(23):5638. doi: 10.3390/cancers15235638.
2
Crosstalk between epigenetics and tumor promoting androgen signaling in prostate cancer.
Vitam Horm. 2023;122:253-282. doi: 10.1016/bs.vh.2022.11.007. Epub 2022 Dec 29.
3
Epigenetic regulation of pluripotency inducer genes NANOG and SOX2 in human prostate cancer.
Prog Mol Biol Transl Sci. 2023;197:241-260. doi: 10.1016/bs.pmbts.2023.01.010. Epub 2023 Mar 2.
4
Epigenetic Regulation in Prostate Cancer Progression.
Curr Mol Biol Rep. 2018;4(2):101-115. doi: 10.1007/s40610-018-0095-9. Epub 2018 Apr 18.
5
Can epigenetic and inflammatory biomarkers identify clinically aggressive prostate cancer?
World J Clin Oncol. 2020 Feb 24;11(2):43-52. doi: 10.5306/wjco.v11.i2.43.
6
Epigenetic reprogramming during prostate cancer progression: A perspective from development.
Semin Cancer Biol. 2022 Aug;83:136-151. doi: 10.1016/j.semcancer.2021.01.009. Epub 2021 Feb 2.
7
The phytochemical 3,3'-diindolylmethane decreases expression of AR-controlled DNA damage repair genes through repressive chromatin modifications and is associated with DNA damage in prostate cancer cells.
J Nutr Biochem. 2017 Sep;47:113-119. doi: 10.1016/j.jnutbio.2017.05.005. Epub 2017 May 25.
8
Epigenetic and Epitranscriptomic Control in Prostate Cancer.
Genes (Basel). 2022 Feb 18;13(2):378. doi: 10.3390/genes13020378.
9
Epigenetics-based diagnostic and therapeutic strategies: shifting the paradigm in prostate cancer.
Epigenomics. 2023 Jan;15(2):75-87. doi: 10.2217/epi-2023-0045. Epub 2023 Mar 28.
10
Epigenetics in prostate cancer: biologic and clinical relevance.
Eur Urol. 2011 Oct;60(4):753-66. doi: 10.1016/j.eururo.2011.06.035. Epub 2011 Jun 22.
引用本文的文献
1
Emerging biomarkers for non-invasive diagnosis and treatment of cancer: a systematic review.
Front Oncol. 2024 Jul 26;14:1405267. doi: 10.3389/fonc.2024.1405267. eCollection 2024.
本文引用的文献
1
Chromatin and Epigenetic Dysregulation of Prostate Cancer Development, Progression, and Therapeutic Response.
Cancers (Basel). 2021 Jul 2;13(13):3325. doi: 10.3390/cancers13133325.
2
Chromatin openness requires continuous SWI/SNF activity.
Nat Genet. 2021 Mar;53(3):263-264. doi: 10.1038/s41588-021-00781-7.
3
Loss and revival of androgen receptor signaling in advanced prostate cancer.
Oncogene. 2021 Feb;40(7):1205-1216. doi: 10.1038/s41388-020-01598-0. Epub 2021 Jan 8.
4
Role of specialized composition of SWI/SNF complexes in prostate cancer lineage plasticity.
Nat Commun. 2020 Nov 3;11(1):5549. doi: 10.1038/s41467-020-19328-1.
5
m6A methyltransferase METTL3 promotes the progression of prostate cancer via m6A-modified LEF1.
Eur Rev Med Pharmacol Sci. 2020 Apr;24(7):3565-3571. doi: 10.26355/eurrev_202004_20817.
6
A high-resolution 3D epigenomic map reveals insights into the creation of the prostate cancer transcriptome.
Nat Commun. 2019 Sep 12;10(1):4154. doi: 10.1038/s41467-019-12079-8.
7
The Metabolic Landscape of Prostate Cancer.
Eur Urol Oncol. 2019 Feb;2(1):28-36. doi: 10.1016/j.euo.2018.06.010. Epub 2018 Jul 19.
8
Androgen Receptor Deregulation Drives Bromodomain-Mediated Chromatin Alterations in Prostate Cancer.
Cell Rep. 2017 Jun 6;19(10):2045-2059. doi: 10.1016/j.celrep.2017.05.049.
9
GSTP1 Methylation and Protein Expression in Prostate Cancer: Diagnostic Implications.
Dis Markers. 2016;2016:4358292. doi: 10.1155/2016/4358292. Epub 2016 Aug 10.
10
One-Carbon Metabolism in Prostate Cancer: The Role of Androgen Signaling.
Int J Mol Sci. 2016 Jul 27;17(8):1208. doi: 10.3390/ijms17081208.
Zotero 插件